A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia
Clinical trial NCT03319953 · COMPLETED
Trial details
- NCT number
- NCT03319953
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2019-09-11
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.